T. Rowe Price Associates’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,697
| Closed | -$1K | – | 3028 |
|
|
2023
Q1 | $1K | Hold |
22,697
| – | – | ﹤0.01% | 2921 |
|
|
2022
Q4 | $1K | Hold |
22,697
| – | – | ﹤0.01% | 2931 |
|
|
2022
Q3 | $1K | Hold |
22,697
| – | – | ﹤0.01% | 2946 |
|
|
2022
Q2 | $2K | Hold |
22,697
| – | – | ﹤0.01% | 2948 |
|
|
2022
Q1 | $4K | Hold |
22,697
| – | – | ﹤0.01% | 2963 |
|
|
2021
Q4 | $13K | Hold |
22,697
| – | – | ﹤0.01% | 2966 |
|
|
2021
Q3 | $18K | Hold |
22,697
| – | – | ﹤0.01% | 2927 |
|
|
2021
Q2 | $24K | Buy |
22,697
+6,766
| +42% | +$7.15K | ﹤0.01% | 2905 |
|
|
2021
Q1 | $14K | Buy |
+15,931
| New | +$14K | ﹤0.01% | 2836 |
|